IS5283A - Lyfjasamsetningar sem innihalda eletriptan hemisúlfat og koffín - Google Patents

Lyfjasamsetningar sem innihalda eletriptan hemisúlfat og koffín

Info

Publication number: IS5283A
Authority: IS; Iceland
Prior art keywords: caffeine; pharmaceutical formulations; pct; formulations containing; eletriptan hemisulfate
Prior art date: 1997-07-03

Application number

IS5283A

Other languages

English (en)

Inventor

Denise Harding Valerie

Billotte Anne

Original Assignee

Pfizer Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-07-03

Filing date

1999-11-30

Publication date

1999-11-30

1997-07-03 Priority claimed from GBGB9714081.8A external-priority patent/GB9714081D0/en

1999-11-30 Application filed by Pfizer Inc. filed Critical Pfizer Inc.

1999-11-30 Publication of IS5283A publication Critical patent/IS5283A/is

Links

RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 title abstract 4
LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 title abstract 2
IYVZCNNIKYUHHM-WXMGBDCWSA-N OS(O)(=O)=O.CN1CCC[C@@H]1CC(C1=C2)=CNC1=CC=C2CCS(=O)(=O)C1=CC=CC=C1.CN1CCC[C@@H]1CC(C1=C2)=CNC1=CC=C2CCS(=O)(=O)C1=CC=CC=C1 Chemical compound OS(O)(=O)=O.CN1CCC[C@@H]1CC(C1=C2)=CNC1=CC=C2CCS(=O)(=O)C1=CC=CC=C1.CN1CCC[C@@H]1CC(C1=C2)=CNC1=CC=C2CCS(=O)(=O)C1=CC=CC=C1 IYVZCNNIKYUHHM-WXMGBDCWSA-N 0.000 title abstract 2
229960001948 caffeine Drugs 0.000 title abstract 2
VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 title abstract 2
239000008194 pharmaceutical composition Substances 0.000 title abstract 2

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Pain & Pain Management (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Child & Adolescent Psychology (AREA)
Hematology (AREA)
Obesity (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

IS5283A 1997-07-03 1999-11-30 Lyfjasamsetningar sem innihalda eletriptan hemisúlfat og koffín IS5283A (is)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB9714081.8A GB9714081D0 (en)	1997-07-03	1997-07-03	Pharmaceutical compositions
GBGB9718270.3A GB9718270D0 (en)	1997-07-03	1997-08-28	Pharmaceutical compositions
PCT/EP1998/004176 WO1999001135A1 (en)	1997-07-03	1998-07-01	Pharmaceutical compositions containing eletriptan hemisulphate and caffeine

Publications (1)

Publication Number	Publication Date
IS5283A true IS5283A (is)	1999-11-30

Family

ID=26311826

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS5283A IS5283A (is)	1997-07-03	1999-11-30	Lyfjasamsetningar sem innihalda eletriptan hemisúlfat og koffín

Country Status (30)

Country	Link
US (1)	US6166025A (is)
EP (1)	EP0999841B1 (is)
JP (1)	JP3350061B2 (is)
CN (1)	CN1145486C (is)
AT (1)	ATE206921T1 (is)
AU (1)	AU724728B2 (is)
BG (1)	BG103930A (is)
BR (1)	BR9810658A (is)
CA (1)	CA2292673C (is)
DE (1)	DE69802097T2 (is)
DK (1)	DK0999841T3 (is)
DZ (1)	DZ2549A1 (is)
EA (1)	EA002174B1 (is)
ES (1)	ES2163291T3 (is)
HR (1)	HRP990416B1 (is)
HU (1)	HUP0004468A3 (is)
ID (1)	ID24528A (is)
IL (1)	IL133206A0 (is)
IS (1)	IS5283A (is)
MA (1)	MA26518A1 (is)
NO (1)	NO312993B1 (is)
NZ (1)	NZ501419A (is)
OA (1)	OA11227A (is)
PL (1)	PL337803A1 (is)
PT (1)	PT999841E (is)
SI (1)	SI0999841T1 (is)
SK (1)	SK284462B6 (is)
TR (1)	TR199903332T2 (is)
UY (1)	UY25078A1 (is)
WO (1)	WO1999001135A1 (is)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9816556D0 (en) *	1998-07-30	1998-09-30	Pfizer Ltd	Therapy
GB9825988D0 (en)	1998-11-27	1999-01-20	Pfizer Ltd	Indole derivatives
GB9922963D0 (en) *	1999-09-28	1999-12-01	Pfizer Ltd	Polymorphic salt
WO2000064448A1 (en)	1999-04-27	2000-11-02	Board Of Regents, The University Of Texas System	A composition and method for treatment of cerebral ischemia
GB9915231D0 (en)	1999-06-29	1999-09-01	Pfizer Ltd	Pharmaceutical complex
IL136961A0 (en) *	1999-06-30	2001-06-14	Pfizer Prod Inc	5ht1 receptor agonists, caffeine and either a cox-2 inhibitor or nsaid for the treatment of migraine
CO5190664A1 (es) *	1999-06-30	2002-08-29	Pfizer Prod Inc	Terapia de combinacion para el tratamiento de migrana administracion de un receptor 5ht, cafeina y un inhibidor de ciclooxigenasa-2
CO5190678A1 (es) *	1999-06-30	2002-08-29	Pfizer Prod Inc	Terapia combinada para el tratamiento de la migrana
GB9923314D0 (en)	1999-10-01	1999-12-08	Pfizer Ltd	Acylation process
US6579898B2 (en) *	2001-03-01	2003-06-17	Pfizer Inc.	Compositions having improved bioavailability
WO2003020977A2 (en) *	2001-08-31	2003-03-13	The University Court Of The University Of Glasgow	Nucleotide repeats assay
US7404489B1 (en)	2003-03-04	2008-07-29	Qol Medical, Llc	Cyanocobalamin low viscosity aqueous formulations for intranasal delivery
US7132549B2 (en)	2003-05-30	2006-11-07	Pfizer Inc.	Process
GB0312478D0 (en) *	2003-05-30	2003-07-09	Pfizer Ltd	Improved process
GB2407498B (en) *	2003-10-30	2008-06-11	Cipla Ltd	Oral formulations for 5-HT receptor agonists with reduced degradation of active ingredient
JP2008516998A (ja) *	2004-10-22	2008-05-22	ジンショウ，コウ	可食用酸と／またはその酸性塩とコーヒーを含む薬剤組成物と無毒性コーヒー
US8506934B2 (en)	2005-04-29	2013-08-13	Robert I. Henkin	Methods for detection of biological substances
WO2007022345A2 (en) *	2005-08-17	2007-02-22	Fleming And Company, Pharmaceuticals	Vitamin b12 nasal spray and method of use
US20070041905A1 (en) *	2005-08-19	2007-02-22	Hoffman Rebecca S	Method of treating depression using a TNF-alpha antibody
WO2008095136A2 (en)	2007-01-31	2008-08-07	Henkin Robert I	Methods for detection of biological substances
FR2926721B1 (fr) *	2008-01-30	2011-07-22	Philippe Perovitch	Forme galenique pour l'adminsitration par voie trans-muqueuse de triptans
US8580801B2 (en)	2008-07-23	2013-11-12	Robert I. Henkin	Phosphodiesterase inhibitor treatment
JP2012036167A (ja) *	2010-07-16	2012-02-23	Taisho Pharmaceutical Co Ltd	内服液剤
US8915245B2 (en) *	2010-10-07	2014-12-23	Vapotherm, Inc.	Nebulizer systems, apparatus and methods for respiratory therapy
JP5887894B2 (ja) *	2010-12-10	2016-03-16	大正製薬株式会社	内服液剤
JP5887893B2 (ja) *	2010-12-10	2016-03-16	大正製薬株式会社	内服液剤
ES2744542T3 (es) *	2013-03-15	2020-02-25	Robert I Henkin	Inhibidores de fosfodiesterasa para tratar trastornos gustativos y olfativos
US10426911B2 (en)	2013-08-08	2019-10-01	Vapotherm, Inc.	Respiratory therapy condensation adaptor
NL1040474C2 (en) *	2013-10-31	2015-05-04	Veramed B V	Nasal compositions stimulating ciliary activity.
US10598672B2 (en)	2014-02-18	2020-03-24	Cyrano Therapeutics, Inc.	Methods and compositions for diagnosing and treating loss and/or distortion of taste or smell
JP6097787B2 (ja) *	2015-06-09	2017-03-15	パルファーマシューティカル，インコーポレーテッド	鼻内送達用シアノコバラミン低粘度水性製剤
FR3053334B1 (fr) *	2016-06-30	2018-07-27	L'oreal	Melange liquide contenant du 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one et de compose de xanthine
WO2021194893A1 (en)	2020-03-24	2021-09-30	Cyrano Therapeutics, Inc.	Treatment of chemosensory dysfunction from a coronavirus infection
AU2024274892A1 (en) *	2023-05-24	2025-12-11	Defuse Technologies, LLC	Desensitized fertilizer compositions and methods of making same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9417310D0 (en) *	1994-08-27	1994-10-19	Pfizer Ltd	Therapeutic agents

1998
- 1998-07-01 SK SK1828-99A patent/SK284462B6/sk unknown
- 1998-07-01 HR HR970276A patent/HRP990416B1/xx not_active IP Right Cessation
- 1998-07-01 EP EP98940152A patent/EP0999841B1/en not_active Expired - Lifetime
- 1998-07-01 HU HU0004468A patent/HUP0004468A3/hu unknown
- 1998-07-01 DE DE69802097T patent/DE69802097T2/de not_active Expired - Fee Related
- 1998-07-01 BR BR9810658-9A patent/BR9810658A/pt not_active Application Discontinuation
- 1998-07-01 DK DK98940152T patent/DK0999841T3/da active
- 1998-07-01 UY UY25078A patent/UY25078A1/es not_active IP Right Cessation
- 1998-07-01 ID IDW991585A patent/ID24528A/id unknown
- 1998-07-01 DZ DZ980159A patent/DZ2549A1/xx active
- 1998-07-01 NZ NZ501419A patent/NZ501419A/xx unknown
- 1998-07-01 SI SI9830068T patent/SI0999841T1/xx unknown
- 1998-07-01 PL PL98337803A patent/PL337803A1/xx unknown
- 1998-07-01 JP JP50638199A patent/JP3350061B2/ja not_active Expired - Fee Related
- 1998-07-01 TR TR1999/03332T patent/TR199903332T2/xx unknown
- 1998-07-01 MA MA25150A patent/MA26518A1/fr unknown
- 1998-07-01 AU AU88569/98A patent/AU724728B2/en not_active Ceased
- 1998-07-01 CN CNB988066289A patent/CN1145486C/zh not_active Expired - Fee Related
- 1998-07-01 IL IL13320698A patent/IL133206A0/xx unknown
- 1998-07-01 CA CA002292673A patent/CA2292673C/en not_active Expired - Fee Related
- 1998-07-01 ES ES98940152T patent/ES2163291T3/es not_active Expired - Lifetime
- 1998-07-01 WO PCT/EP1998/004176 patent/WO1999001135A1/en not_active Ceased
- 1998-07-01 AT AT98940152T patent/ATE206921T1/de not_active IP Right Cessation
- 1998-07-01 US US09/402,239 patent/US6166025A/en not_active Expired - Fee Related
- 1998-07-01 EA EA199901100A patent/EA002174B1/ru not_active IP Right Cessation
- 1998-07-01 PT PT98940152T patent/PT999841E/pt unknown
1999
- 1999-11-30 IS IS5283A patent/IS5283A/is unknown
- 1999-11-30 BG BG103930A patent/BG103930A/xx unknown
- 1999-12-01 NO NO19995887A patent/NO312993B1/no unknown
- 1999-12-03 OA OA9900271A patent/OA11227A/en unknown

Also Published As

Publication number	Publication date
JP2000516262A (ja)	2000-12-05
ATE206921T1 (de)	2001-11-15
AU724728B2 (en)	2000-09-28
HK1029282A1 (en)	2001-03-30
CN1261279A (zh)	2000-07-26
EA199901100A1 (ru)	2000-08-28
ID24528A (id)	2000-07-20
HRP990416A2 (en)	2000-04-30
JP3350061B2 (ja)	2002-11-25
PL337803A1 (en)	2000-09-11
CA2292673C (en)	2003-04-22
DZ2549A1 (fr)	2003-02-08
IL133206A0 (en)	2001-03-19
DE69802097T2 (de)	2002-03-14
CA2292673A1 (en)	1999-01-14
PT999841E (pt)	2002-02-28
DK0999841T3 (da)	2001-11-19
SK284462B6 (sk)	2005-04-01
MA26518A1 (fr)	2004-12-20
NO995887D0 (no)	1999-12-01
NO312993B1 (no)	2002-07-29
BG103930A (en)	2000-07-31
NZ501419A (en)	2000-09-29
EP0999841B1 (en)	2001-10-17
AU8856998A (en)	1999-01-25
HUP0004468A3 (en)	2004-07-28
EP0999841A1 (en)	2000-05-17
UY25078A1 (es)	2000-12-29
BR9810658A (pt)	2000-10-03
ES2163291T3 (es)	2002-01-16
EA002174B1 (ru)	2002-02-28
SK182899A3 (en)	2000-09-12
SI0999841T1 (is)	2001-12-31
NO995887L (no)	2000-03-02
HUP0004468A2 (hu)	2001-10-28
OA11227A (en)	2003-07-18
WO1999001135A1 (en)	1999-01-14
TR199903332T2 (xx)	2000-09-21
HRP990416B1 (en)	2002-04-30
US6166025A (en)	2000-12-26
DE69802097D1 (de)	2001-11-22
CN1145486C (zh)	2004-04-14

Publication	Publication Date	Title
NO995887D0 (no)	1999-12-01	Farmasöytiske blandinger inneholdende eletripan hemisulfat og koffein
MY118151A (en)	2004-09-30	Pharmaceutical formulations containing voriconazole.
MX9707431A (es)	1997-12-31	Inhibidores de la proteina cinasa c.
IL133825A0 (en)	2001-04-30	Substituted 6-phenylphenanthridines, medicaments containing same and use thereof
MX9803792A (es)	1998-09-30	Inhibidor de proteina cinasa c.
IL149163A0 (en)	2002-11-10	Piperazine derivatives of carbazole, their preparation and pharmaceutical compositions containing them
ATE219765T1 (de)	2002-07-15	Indolderivate als cgmp-pde inhibitoren
DE69727922D1 (de)	2004-04-08	Schnell zerfallende orale dosierungsform
GEP20063885B (en)	2006-08-10	Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
IL132608A0 (en)	2001-03-19	Fused dihydropyran compounds medicaments containing the same and the use thereof
AP1424A (en)	2005-06-06	2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens.
TNSN04034A1 (en)	2006-06-01	Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
ZA971279B (en)	1998-08-14	Use of 5ht4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhinitors
ATE310738T1 (de)	2005-12-15	Gesättigte 1,2-dithiaheterocyclische verbindungen enthaltende antivirale pharmazeutische zubereitungen
BG106155A (en)	2002-08-30	Novel derivatives and analogues of galanthamin
AU3868997A (en)	1998-03-19	Pharmaceutical composition containing osteogenesis-promoting substance and a polyethylene glycol
IL141236A0 (en)	2002-03-10	New oral formulations for 5-ht4 agonists or antagonists
ZA200303113B (en)	2004-07-23	Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them.
AU3777197A (en)	1998-02-25	Cyclosporin formulation
PL318130A1 (en)	1997-05-12	Terpenod derivatives (of sarcodictyine)as antineoplastic agents
AP2001002369A0 (en)	2001-12-31	Pharmaceutical complex.
IL102058A0 (en)	1992-12-30	Pharmaceutical compositions containing a nucleoside derivative
EP1263435A4 (en)	2004-08-11	PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND PREVENTION OF LIVER CIRRHOSIS AND CIRRHOSIS
MY119643A (en)	2005-06-30	Pharmaceutical compositions containing eletriptan hemisulphate and caffeine
ECSP982578A (es)	1999-02-11	Composiciones farmaceuticas que contienen eletriptan hemisulfato